Stay updated with the latest from BreezeBio

All Catch Up With Press Releases Announcements

GenEdit Achieves First Milestone from Collaboration and License Agreement with Genentech

GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology

GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease

GenEdit Announces Series A1 Financing

GenEdit Is a Phase I Winner of the NIH TARGETED Challenge

Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases

GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery